Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05433662 · ClinicalTrials.gov registry record
Telehealth Acceptance and Commitment Therapy for Older Veterans Experiencing Pandemic-Related Stress
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 24
- Enrollment target
NCT05433662: Completed study, sponsored by VA Office of Research and Development.
NCT05433662 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05433662 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Older adults have been disproportionately impacted and distressed by the COVID-19 pandemic. Social distancing and stay-at-home orders have increased older adults' risk of social isolation and loneliness that will has led to a pandemic-induced fear of being in close proximity to other people. These fears and avoidant behaviors will have lasting effects if not treated with effective, safe, and convenient psychological interventions. This study will evaluate the acceptability and feasibility of delivering a small group intervention, called Acceptance and Commitment Therapy (ACT), through a telehealth modality to Veterans ages 65 and older who are experiencing pandemic-related emotional and physical distress. ACT helps decrease emotional suffering, improve well-being and promote positive behavior change by increasing one's psychological flexibility through the practice of mindfulness, acceptance, and values-based behaviors. The knowledge gained from this study will be used to better tailor the invention to meet the needs of older Veterans in an era of post-pandemic recovery.
Primary Outcome
Retention is defined as number of participants who completed the post-treatment endpoint assessment (numerator) divided by the number of participants who signed informed consent (enrolled; denominator).
Interventions
- BEHAVIORAL Pandemic Acceptance and Commitment Therapy (Pan-ACT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-06-15 |
| Est. Completion | 2025-01-23 |
What the finished NCT05433662 record still lists
NCT05433662 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pandemic Acceptance and Commitment Therapy (Pan-ACT) is the first listed.
NCT05433662 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05433662 about?
NCT05433662 is a clinical study titled "Telehealth Acceptance and Commitment Therapy for Older Veterans Experiencing Pandemic-Related Stress". Older adults have been disproportionately impacted and distressed by the COVID-19 pandemic. Social distancing and stay-at-home orders have increased older adults' risk of social isolation and loneliness that will has led to a pandemic-induced fear of being in close proximity to other people. These f...
What is the current status of trial NCT05433662?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2022-06-15. Estimated completion is 2025-01-23.
What interventions are being tested in trial NCT05433662?
The interventions under investigation include: Pandemic Acceptance and Commitment Therapy (Pan-ACT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05433662?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI